Mind Medicine, Inc.

Mind Medicine, Inc.

Toronto-based company developing drugs for use in psychedelic therapy protocols.

Mind Medicine (MindMed) Inc. announced that in collaboration with University Hospital Basel's Liechti Laboratory, it has discovered and filed a patent application in the United States (preserving all worldwide rights) for a neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session.

This discovery, when further developed, may act as the 'off-switch' to an LSD trip.

MindMed is the leading psychedelic pharmaceutical company and the Liechti Laboratory is the leading research center focused on the pharmacology of psychedelic substances.

The invention may help reduce the acute effects of a psychedelic drug and help shorten the hallucinogenic effects when required by a patient or medical professional.

Timeline

People

Name
Role
LinkedIn

Carol Nast

Chief Operating Officer

Collin Gage

Head of Corporate Development

Dave Guebert

Chief Financial Officer

Donald Gehlert, PhD

Chief Scientific Officer

Jamon Rahn

Co-Founder, Director & Co-CEO

Jeanne Bonelle

EVP, Technical Operations

Madeline Feldman

Director of Operations & Administration

Nico Forte

Senior Director, Business Operations and Development

Scott Freeman, MD

Co-Founder, Chief Medical Officer

Stephen L. Hurst, JD

Co-Founder, Executive Chair & Co-CEO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.